-
V5 Epitope Tagging: From Detection to Dynamics
2026-09-13
The V5 Epitope Tag Peptide is more than a convenient antigen: it can serve as a defined control, assay-calibration reagent, and bridge between recombinant protein expression, immunodetection, and emerging single-molecule imaging. This article connects the GKPIPNPLLGLDST peptide to antibody kinetics, translational assay design, and practical workflow decisions.
-
Gly-Gly-Phe-Gly: A Rigorous Linker Guide
2026-09-12
Explore how Gly-Gly-Phe-Gly (GGFG) functions as a sequence-defined peptide spacer for bioconjugation, peptide engineering, and biomaterial construction. This guide also translates modern peptide–metal-ion methodology into practical assay and linker-design decisions while clearly separating evidence from workflow recommendations.
-
ETS1–SENP2 Axis Restrains Mitophagy in BPD
2026-09-11
The reference study identifies ETS1 as a transcriptional regulator that protects against hyperoxia-associated bronchopulmonary dysplasia by activating the SENP2/HSPA8/FUNDC1 axis. Its findings connect FUNDC1 deSUMOylation, chaperone-mediated degradation, and excessive mitophagy, providing a mechanistic framework for studying mitochondrial quality control in developing lung tissue.
-
Dual-Action p38α Inhibition and Dephosphorylation
2026-09-11
The reference preprint shows that selected kinase inhibitors can do more than occupy the p38α active site: they can also stabilize an activation-loop conformation that accelerates WIP1-mediated dephosphorylation. This mechanism links kinase inhibition with phosphatase-driven signal termination and offers a structural framework for designing more durable and selective p38 MAPK inhibitors.
-
Lassa Virus Spike pH Switching and Entry Inhibition
2026-09-10
This 2025 Cell Host & Microbe study defines how pH-dependent structural transitions prepare the Lassa virus spike for receptor release and membrane fusion. High-resolution structural analysis and ARN-75039 validation connect early transmembrane remodeling with later spike opening, providing a mechanistic framework for antiviral entry inhibition and for interpreting carefully preserved structural samples.
-
Regulated N-Glycosylation at the Secretory Translocon
2026-09-10
This study defines how CCDC134 and OST-A regulate GRP94 glycosylation during synthesis at the ER translocon. Structural and functional evidence shows that a nascent GRP94 segment remodels the translocon, suppresses inappropriate OST-A activity, and limits access by OST-B, providing a mechanistic explanation for regulated N-glycosylation and its links to proteostasis.
-
SmD2 Acetylation and PARP Sensitivity in HCC
2026-09-09
This 2024 Nature Communications study identifies acetylation-dependent control of the spliceosome protein SmD2 as a regulator of BRCA1/FANC cassette exons, DNA repair, and PARP inhibitor response in hepatocellular carcinoma. Its findings support a mechanistic strategy in which HDAC2 or SmD2 regulation is combined with PARP inhibition, particularly in HCC models that do not depend on canonical BRCA1/2 deficiency.
-
Canagliflozin: SGLT2 Inhibitor Research Guide
2026-09-09
Canagliflozin is a selective SGLT2 inhibitor used to study renal glucose reabsorption inhibition and glucose metabolism modulation. Recent mouse evidence links treatment with proximal-tubule mitochondrial remodeling, improved bioenergetics in males, and reduced albuminuria under a hypertensive-diabetic model.
-
BOP Reagent for Peptide and Prodrug Design
2026-09-08
BOP reagent is a solid peptide coupling reagent for carboxyl group activation and amide bond formation. The supplier reports 98% purity, organic-solvent solubility, and desiccated storage at −20 °C, while current OSCC evidence supports a separate carrier-free triterpene prodrug platform rather than direct evidence for BOP use.
-
Triterpene Prodrug for Targeted OSCC Therapy
2026-09-08
This study develops a carrier-free, self-assembled prodrug from glycyrrhetinic acid and ginsenoside Rh2 for targeted oral squamous cell carcinoma chemotherapy. Its central innovation is a thioketal-linked glycyrrhetinic acid dimer that uses tumor-associated reactive oxygen species to trigger drug release while glycyrrhetinic acid amplifies oxidative stress.
-
G-15: G Protein-Coupled Estrogen Receptor Antagonist
2026-09-07
G-15 is a selective G protein-coupled estrogen receptor antagonist for separating GPR30/GPER signaling from classical estrogen receptor activity. This guide translates its reported calcium, PI3K/Akt, proliferation, and in vivo effects into practical assay workflows, controls, and troubleshooting strategies.
-
Cefodizime Workflows for Resistance Research
2026-09-07
Build susceptibility, resistance-surveillance, and immune-interaction assays around Cefodizime, a third-generation cephalosporin antibiotic with defined Gram-positive and Gram-negative activity. This workflow translates hospital utilization data into practical experimental controls while highlighting target-organism limitations and reproducibility safeguards.
-
Proteinase K for DNA Prep and Protease Assays
2026-09-05
Proteinase K combines broad protein hydrolysis with compatibility across buffers, detergents, EDTA, and moderate heating, making it useful for high-integrity DNA preparation and enzyme-contaminant removal. Its contrasting behavior in a SARS-CoV-2 protease screen also makes it a practical counter-screen for separating selective inhibitor activity from nonspecific protease inhibition.
-
3X FLAG Peptide: From Tag to Translation
2026-09-04
A mechanistic and strategic guide to using the 3X (DYKDDDDK) Peptide in interactome analysis, FLAG fusion-protein workflows, structural biology, and translational research. The article connects the CUL3-KEAP1–PHD2 study to practical decisions around affinity capture, immunodetection, metal control, and evidence quality.
-
Chenodeoxycholic Acid: FXR Research Workflows
2026-09-04
Chenodeoxycholic Acid provides a practical chemical entry point for activating FXR in cholesterol metabolism research, liver function studies, and renal injury models. This workflow translates the reported FXR–KLF11 mechanism into formulation, cell-based, transcriptional, and troubleshooting strategies while separating established findings from optimization starting points.